Pharmaceuticals company Mylan's CEO Heather Bresch reportedly has received a salary hike of 671% to $18.9 million in 8 years, from 2007 to 2015. Notably, the company hiked the wholesale price of its major product EpiPen by 400% in the same period. EpiPen is a device that provides calibrated dosage in the case of anaphylaxis, a potentially life-threatening allergic reaction.